First ASTar® evaluation in Abu Dhabi, United Arab Emirates

Q-linea AB (publ) (OMX: QLINEA) today announces the initiation of the first clinical evaluation of ASTar at Sheikh Kalifa Medical City, Abu Dhabi (UAE).

This is the first ASTar evaluation in the Gulf Cooperation Council Region following recent clearance by the local authorities. The evaluation will include patient specimens, and it is being conducted in preparation for a ramp up of routine rapid antibiotic susceptibility testing (rapid AST).
 
“We are very pleased with how quickly projects are progressing in the Region thanks to the highly professional work done by AMICO Group, our partner in the Region. Given the high interest in rAST demonstrated during congresses and other customer interactions, we expect to initiate further evaluations in the region in the near future” said Franco Pellegrini, VP Sales EMEA at Q-linea.

Datum 2025-04-08, kl 14:15
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!